NBSE insider filings
NeuBase Therapeutics, Inc. — 6 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-09-18. Screen NBSE transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for NBSE between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — NeuBase Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-09-18 | 4 | Symetryx Corp — 10% owner | Sale (S): 129,108 @ $1.44 · Sale (S): 103,337 @ $1.26 · Sale (S): 50,000 @ $1.19 | EDGAR |
| 2023-09-11 | 4 | Symetryx Corp — 10% owner | Sale (S): 74,852 @ $1.80 · Sale (S): 128,847 @ $1.53 · Sale (S): 3,376 @ $1.44 | EDGAR |
| 2023-09-07 | 4 | Symetryx Corp — 10% owner | Purchase (P): 61,076 @ $0.98 | EDGAR |
| 2023-08-04 | 4 | Stephan Dietrich A — Founder and CEO, Director, 10% owner | Option exercise (M): 93,234 @ $0.02 · Option exercise (M): 93,234 (derivative) @ $0 | EDGAR |
| 2023-03-17 | 4 | Branning Todd P. — Chief Financial Officer | Grant/award (A): 54,200 @ $0 | EDGAR |
| 2023-03-17 | 4 | Stephan Dietrich A — CEO and Director, Director, 10% owner | Grant/award (A): 153,000 @ $0 | EDGAR |
Recent 8-K events — NeuBase Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-01-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-06-27 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-05-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-05-22 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-05-13 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-05-03 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-04-05 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-23 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NBSE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →